Incidence and outcome of idiopathic pneumonia syndrome in pediatric stem cell transplant recipients

Bone Marrow Transplantation

Volumn 38, Issue 4, 2006, Pages 285-289

  Keates Baleeiro, J ^a   Moore, P ^b   Koyama, T ^b   Manes, B ^a   Calder, C ^a   Frangoul, H ^a  

^a MONROE CARELL JR CHILDREN S HOSPITAL AT VANDERBILT   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOSPORIN; CYTARABINE; ETANERCEPT; INFLIXIMAB; MELPHALAN; METHOTREXATE; METHYLPREDNISOLONE; OXYGEN; PREDNISONE; STEROID; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ASSISTED VENTILATION; CAUSE OF DEATH; CHILD; CHILDHOOD CANCER; CHRONIC GRAFT VERSUS HOST DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; DONOR; FEMALE; GRAFT RECIPIENT; HUMAN; HUMAN CELL; HYPOXIA; IDIOPATHIC DISEASE; INCIDENCE; INFANT; LUNG INFECTION; LUNG INFILTRATE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; OXYGENATION; PNEUMONIA; PRIORITY JOURNAL; PULSE OXIMETRY; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; THORAX RADIOGRAPHY;

ADOLESCENT; ADULT; ANOXIA; CAUSE OF DEATH; CHILD; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; INFANT; MALE; PNEUMONIA; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 33746970456     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705436     Document Type: Review

References (27)

1. Geller RB, Vogelsang GB, Wingard JR, Yeager AM, Burns WH, Santos GW et al. Successful marrow transplantation for acute myelocytic leukemia following therapy for Hodgkin's disease. J Clin Oncol 1988; 6: 1558-1561.
2. Weiner RS, Dicke KA. Risk factors for interstitial pneumonitis following allogeneic bone marrow transplantation for severe aplastic anemia: A preliminary report. Transplant Proc 1987; 19 (Part 3): 2639-2642.
3. Kantrow SP, Hackman RC, Boeckh M, Myerson D, Crawford SW. Idiopathic pneumonia syndrome: Changing spectrum of lung injury after marrow transplantation. Transplantation 1997; 63: 1079-1086.
4. Crawford SW, Hackman RC. Clinical course of idiopathic pneumonia after bone marrow transplantation. Am Rev Respir Dis 1993; 147 (Part 1): 1393-1400.
5. Afessa B, Litzow MR, Tefferi A. Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 28: 425-434.
6. Shankar G, Cohen DA. Idiopathic pneumonia syndrome after bone marrow transplantation: The role of pre-transplant radiation conditioning and local cytokine dysregulation in promoting lung inflammation and fibrosis. Int J Exp Pathol 2001; 82: 101-113.
7. Della Volpe A, Ferreri AJ, Annaloro C, Mangili P, Rosso A, Calandrino R et al. Lethal pulmonary complications significantly correlate with individually assessed mean lung dose in patients with hematologic malignancies treated with total body irradiation. Int J Radiat Oncol Biol Phys 2002; 52: 483-488.
8. Clark JG, Hansen JA, Hertz MI, Parkman R, Jensen L, Peavy HH. NHLBI workshop summary. Idiopathic pneumonia syndrome after bone marrow transplantation. Am Rev Respir Dis 1993; 147 (Part 1): 1601-1606.
9. Pecego R, Hill R, Appelbaum FR, Amos D, Buckner CD, Fefer A et al. Interstitial pneumonitis following autologous bone marrow transplantation. Transplantation 1986; 42: 515-517.
10. Granena A, Carreras E, Rozman C, Salgado C, Sierra J, Algara M et al. Interstitial pneumonitis after BMT: 15 years experience in a single institution. Bone Marrow Transplant 1993; 11: 453-458.
11. Meyers JD, Flournoy N, Thomas ED. Nonbacterial pneumonia after allogeneic marrow transplantation: A review of ten years' experience. Rev Infect Dis 1982; 4: 1119-1132.
12. Wingard JR, Mellits ED, Sostrin MB, Chen DY, Burns WH, Santos GW et al. Interstitial pneumonitis after allogeneic bone marrow transplantation. Nine-year experience at a single institution. Medicine (Baltimore) 1988; 67: 175-186.
13. Fukuda T, Hackman RC, Guthrie KA, Sandmaier BM, Boeckh M, Maris MB et al. Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation. Blood 2003; 102: 2777-2785.
14. Yanik G, Hellerstedt B, Custer J, Hutchinson R, Kwon D, Ferrara JL et al. Etanercept (Enbrel) administration for idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2002; 8: 395-400.
15. Clark JG, Madtes DK, Martin TR, Hackman RC, Farrand AL, Crawford SW. Idiopathic pneumonia after bone marrow transplantation: Cytokine activation and lipopolysaccharide amplification in the bronchoalveolar compartment. Crit Care Med 1999; 27: 1800-1806.
16. Weiner RS, Bortin MM, Gale RP, Gluckman E, Kay HE, Kolb HJ et al. Interstitial pneumonitis after bone marrow transplantation. Assessment of risk factors. Ann Intern Med 1986; 104: 168-175.
17. Crawford SW, Longton G, Storb R. Acute graft-versus-host disease and the risks for idiopathic pneumonia after marrow transplantation for severe aplastic anemia. Bone Marrow Transplant 1993; 12: 225-231.
18. Atkinson K, Nivison-Smith I, Dodds A, Concannon A, Milliken S, Downs K. A comparison of the pattern of interstitial pneumonitis following allogeneic bone marrow transplantation before and after the introduction of prophylactic ganciclovir therapy in 1989. Bone Marrow Transplant 1998; 21: 691-695.
19. Griese M, Rampf U, Hofmann D, Fuhrer M, Reinhardt D, Bender-Gotze C. Pulmonary complications after bone marrow transplantation in children: twenty-four years of experience in a single pediatric center. Pediatr Pulmonol 2000; 30: 393-401.
20. Atkinson K, Turner J, Biggs JC, Dodds A, Concannon A. An acute pulmonary syndrome possibly representing acute graft-versus-host disease involving the lung interstitium. Bone Marrow Transplant 1991; 8: 231-234.
21. Down JD, Mauch P, Warhol M, Neben S, Ferrara JL. The effect of donor T lymphocytes and total-body irradiation on hemopoietic engraftment and pulmonary toxicity following experimental allogeneic bone marrow transplantation. Transplantation 1992; 54: 802-808.
22. Cooke KR, Kobzik L, Martin TR, Brewer J, Delmonte Jr J, Crawford JM et al. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. Blood 1996; 88: 3230-3239.
23. Cooke KR, Hill GR, Gerbitz A, Kobzik L, Martin TR, Crawford JM et al. Tumor necrosis factor-alpha neutralization reduces lung injury after experimental allogeneic bone marrow transplantation. Transplantation 2000; 70: 272-279.
24. Cooke KR, Yanik G. Acute lung injury after allogeneic stem cell transplantation: Is the lung a target of acute graft-versus-host disease? Bone Marrow Transplant 2004; 34: 753-765.
25. Cooke KR. Acute lung injury after allogeneic stem cell transplantation: from the clinic, to the bench and back again. Pediatr Transplant 2005; 9 (Suppl 7): 25-36.
26. Yanik G, Cooke KR. The lung as a target organ of graft-versus-host disease. Semin Hematol 2006; 43: 42-52.
27. Yanik GA, Levine JE, Ferrara JLM, Uberti JP, Ho VT, Antin JH et al. Survival following etanercept therapy for the treatment of Idiopathic pneumonia syndrome post allogeneic stem cell transplantation. Blood 2004; 104: 104A-105A.